What Will the Stock Market Do Today? 3 Big Stories to Watch.

Good morning and welcome to the stock market today! A look at some of the top market gainers and losers this morning gives investors a taste of what to expect — lots of crypto news, penny stock stumbles and merger excitement. So what else will the stock market do today? Dive in with InvestorPlace.

Street sign for Wall Street pictured in front of several American flags representing american stocks

Source: Shutterstock

To start, the major indices are split. The Dow Jones Industrial Average took the biggest hit on Tuesday, and is now down 0.49%. The S&P 500 is flat, and the Nasdaq Composite has actually powered higher, gaining 0.74%.

So what else will the stock market do today? Here are the top stories you should be watching.

What Will the Stock Market Do Today? Talk Vaccines.

Today the U.S. Food and Drug Administration asked states to pause the rollout of the Johnson & Johnson (NYSE:JNJ) vaccine, acting “out of an abundance of caution.” This follows reports of a rare blood clotting disorder in six women who had received the vaccine.

According to the FDA, all six cases of this blood clotting disorder occurred in women ages 18 to 48. Symptoms developed six to 13 days after these women received the single-shot Covid-19 vaccine. Additionally, the FDA says that the standard treatment for that type of blood clot could be dangerous in this situation, further complicating matters.

At this point, 6.8 million Americans have received the Johnson & Johnson vaccine, leading regulators to say that this side effect appears extremely rare. Johnson & Johnson has also said there is no clear relationship between its vaccine and the blood clotting disorder, although it is working with regulators. The FDA said it will hold a press conference with the Centers for Disease Control and Prevention at 10 a.m. Eastern.

So where do things go from here? Already, health officials are warning that this will complicate the vaccine rollout in the United States. Dr. Kavita Patel, a primary care physician, told CNBC that it will be hard for Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) to fill in the gaps with their two-shot vaccines. Additionally, fear of these side effects could affect consumer demand for the Covid-19 shots.

For the stock market, we may see an initial rally in PFE stock, MRNA stock and BioNTech (NASDAQ:BNTX) stock. A stumble for a major competitor is a victory, right? Not so fast. Although Pfizer and Moderna may gain on Tuesday, the longer-term victory for Wall Street comes in widespread vaccination. It will be important for investors to follow the news and stay up-to-date with what the FDA is recommending.

JNJ stock is down more than 2.5% at the time of writing. MRNA stock is up more than 6%.

The Coinbase IPO Gives Bitcoin a Record Push

Bitcoin (CCC:BTC) hit a new all-time high above $63,000 this morning. Ethereum (CCC:ETH) touched a new high of its own, coming in above $2,200 for the first time ever. Altcoins like XRP (CCC:XRP), Dogecoin (CCC:DOGE) and Stellar (CCC:XLM) are also big gainers on Tuesday morning.

So where do these moves come from? Broadly, cryptocurrency sentiment has been hot, with mainstream support growing since the end of 2020. Major institutions are climbing on board, with Tesla (NASDAQ:TSLA) rolling out payment integrations and Walmart (NYSE:WMT) allegedly adding BTC to its balance sheet. Regulators are also warming up, with applications for Bitcoin exchange-traded funds rushing in. Just yesterday, Canadian firm Galaxy Digital (OTCMKTS:BRPHF) gained on news it had submitted its application for a U.S. Bitcoin ETF.

While these catalysts are certainly help heat up the crypto space, the Coinbase IPO is another huge driver. COIN stock is set to start trading on April 14, and Wall Street is ready.

In fact, with analysts setting price targets on COIN stock as high as $600, it is clear why the interest is so huge. Simply put, Coinbase is a huge player in the crypto space. Experts believe it has a real impact on the cryptocurrencies listed on its platform, and its IPO signifies a milestone in the race to relevancy. Ahead of and following the Coinbase IPO, expect a broader re-rating of crypto assets.

What Else We’re Watching

On the date of publication, Sarah Smith did not have (either directly or indirectly) any positions in the securities mentioned in this article. 

Sarah Smith is a Web Content Producer with InvestorPlace.com. 

Article printed from InvestorPlace Media, https://investorplace.com/2021/04/what-will-the-stock-market-do-today-3-big-stories-coinbase-ipo-jnj-stock-fda-agc-stock/.

©2023 InvestorPlace Media, LLC